Related Experiment Video
Updated: Aug 18, 2026

Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment
Published on: November 23, 2017
Priming of human monocytes with PAF augments their production of tumor necrosis factor
1Immunology Division, Faculty of Medicine, University of Sherbrooke, Que., Canada.
Abstract:
We have recently shown that platelet-activating factor (PAF) can markedly enhance the production of tumor necrosis factor (TNF) and interleukin-1 (IL-1) by human monocytes stimulated with lipopolysaccharide or muramyl dipeptide (MDP). Because inflammatory mediators may act sequentially in vivo, we studied the effect of preexposure of monocytes to PAF on their subsequent response to cytokines in terms of TNF production. Priming monocytes for 18-48 h with graded concentrations of PAF (10(-16)-10(-6) M) markedly enhanced their subsequent TNF production in response to MDP and MDP + cytokines, by two- to three-fold. Our data suggest that priming of monocytes by PAF may be an important step in augmenting their subsequent activities in inflammatory or immune responses.
Insights
Platelet-activating factor (PAF) primes human monocytes, significantly boosting their production of tumor necrosis factor (TNF) and interleukin-1 (IL-1). This priming enhances subsequent inflammatory and immune responses.
Area of Science:
- Immunology
- Cell Biology
- Inflammation Research
Background:
- Platelet-activating factor (PAF) is known to enhance cytokine production in monocytes.
- Inflammatory mediators can act sequentially in vivo, necessitating studies on their temporal interactions.
- Understanding monocyte priming is crucial for deciphering inflammatory and immune response dynamics.
Purpose of the Study:
- To investigate the effect of PAF pre-exposure on human monocyte response to subsequent stimuli.
- To determine how PAF priming influences tumor necrosis factor (TNF) production by monocytes.
- To elucidate the role of PAF in augmenting monocyte activity in inflammatory contexts.
Main Methods:
- Human monocytes were pre-exposed to varying concentrations of platelet-activating factor (PAF) for 18-48 hours.
- Subsequent TNF production was measured in response to stimulation with muramyl dipeptide (MDP) and/or cytokines.
- Comparative analysis of TNF production in primed versus unprimed monocytes.
Main Results:
- Pre-exposure to PAF markedly enhanced subsequent TNF production by human monocytes.
- This enhancement was observed in response to both MDP and MDP + cytokines stimulation.
- The TNF production was increased by two- to three-fold following PAF priming.
Conclusions:
- Priming human monocytes with PAF significantly augments their capacity for TNF production.
- PAF-mediated priming appears to be a key mechanism in amplifying monocyte responses.
- These findings suggest PAF plays an important role in modulating inflammatory and immune activities.
More Related Videos
11:48Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019